ABM Industries (ABM)
(Delayed Data from NYSE)
$57.73 USD
+0.77 (1.35%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $57.77 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.73 USD
+0.77 (1.35%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $57.77 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Inspire Medical (INSP) Gets FDA Nod for Inspire V System
by Zacks Equity Research
Inspire Medical (INSP) secures FDA approval for its advanced Inspire V therapy system, featuring an innovative neurostimulator and Bluetooth technology for enhanced patient and physician control.
Is Charles River Associates (CRAI) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and ABM Industries (ABM) have performed compared to their sector so far this year.
Ecolab (ECL) Sells Surgical Solutions Business to Medline
by Zacks Equity Research
Ecolab's (ECL) deal to sell its global surgical solutions business to Medline enables it to focus on infection prevention and instrument reprocessing while enhancing shareholders' returns.
CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut
by Zacks Equity Research
CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.
Stryker's (SYK) Q2 Earnings Beat Estimates, Guidance Raised
by Zacks Equity Research
Stryker (SYK) beats second-quarter earnings estimates, driven by robust sales growth and innovative launches like the LIFEPAK 35 and Spine Guidance 5. The company raises 2024 guidance.
Avantor's (AVTR) Q2 Earnings Beat, Operating Margin Declines
by Zacks Equity Research
Avantor's (AVTR) revenues decline in the second quarter with new segmental changes. Bioprocessing orders decline. Operating margin contracts.
Are Investors Undervaluing ABM Industries (ABM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
DexCom's (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth. Shares fall.
Republic Services (RSG) Earnings Surpass Estimates in Q2
by Zacks Equity Research
Republic Services' (RSG) top and bottom lines increase year over year in second-quarter 2024.
Is the Options Market Predicting a Spike in ABM Industries (ABM) Stock?
by Zacks Equity Research
Investors need to pay close attention to ABM Industries (ABM) stock based on the movements in the options market lately.
Is S&P Global (SPGI) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how S&P Global (SPGI) and ABM Industries (ABM) have performed compared to their sector so far this year.
ABM Industries (ABM) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
ABM Industries (ABM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy ABM Industries (ABM) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Broker-Loved Stocks to Keep an Eye on in the Current Scenario
by Maharathi Basu
Investors would do well to keep a tab on stocks like Air Transport Services (ATSG), Allegiant Travel (ALGT), ABM Industries (ABM), American Axle (AXL) and Warner Bros. (WBD).
ABM Industries (ABM) Stock Rises 22.5% in a Year: Here's How
by Zacks Equity Research
ABM Industries' (ABM) multi-year comprehensive strategic plan, ELEVATE, focuses on providing clients with offerings that enhance transparency and efficiencies.
Accenture (ACN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2024 revenues and earnings are expected to have declined year over year.
4 Broker-Favorite Stocks to Monitor Post Analyst Upgrades
by Maharathi Basu
Investors would do well to keep a tab on stocks like Bread Financial (BFH), ABM Industries (ABM), Centene (CNC) and AdvanSix (ASIX).
ABM Industries (ABM) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
ABM Industries' (ABM) top line benefits from a strong segmental performance in the second quarter of fiscal 2024.
ABM Industries (ABM) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for ABM Industries (ABM) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ABM Industries (ABM) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ABM Industries (ABM) delivered earnings and revenue surprises of 11.54% and 0.95%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about ABM Industries (ABM) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for ABM Industries (ABM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended April 2024.
Are Investors Undervaluing ABM Industries (ABM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why ABM Industries (ABM) Stock is a Great Pick Now
by Zacks Equity Research
ABM Industries (ABM) benefits from strong demand in its aviation front, client additions in its education segment and Elevate investments.
Is Byrna Technologies (BYRN) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Byrna Technologies Inc. (BYRN) and ABM Industries (ABM) have performed compared to their sector so far this year.
Should Value Investors Buy ABM Industries (ABM) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.